You are here: Home Published Research Immunogenicity, safety, and reactogenicity of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine and DTPa-IPV-Hib when coadministered as a 3-dose primary vaccination schedule in The Netherlands: a randomized controlled trial.

Menno R van den Bergh, Judith Spijkerman, Nancy Fran├žois, Kristien Swinnen, Dorota Borys, Lode Schuerman, Reinier H Veenhoven, and Elisabeth AM Sanders (2011)

Immunogenicity, safety, and reactogenicity of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine and DTPa-IPV-Hib when coadministered as a 3-dose primary vaccination schedule in The Netherlands: a randomized controlled trial.

The Pediatric infectious disease journal, 30(9):e170–e178.

Recent reviews have highlighted the unpredictability of immunologic interference when multivalent conjugated vaccines are coadministered with other pediatric vaccines.

Antibodies, Bacterial, Antibodies, Viral, Bacterial Proteins, Carrier Proteins, Diphtheria-Tetanus-Pertussis Vaccine, Haemophilus Vaccines, Humans, Immunization Schedule, Immunoglobulin D, Infant, Lipoproteins, Netherlands, Pneumococcal Vaccines, Poliovirus Vaccine, Inactivated, Vaccination, Vaccines, Combined, Vaccines, Conjugate
Antibodies, Bacterial, Antibodies, Viral, Bacterial Proteins, Carrier Proteins, Diphtheria-Tetanus-Pertussis Vaccine, Haemophilus Vaccines, Humans, Immunization Schedule, Immunoglobulin D, Infant, Lipoproteins, Netherlands, Pneumococcal Vaccines, Poliovirus Vaccine, Inactivated, Vaccination, Vaccines, Combined, Vaccines, Conjugate
 
Document Actions